In conclusion, our data suggests that GPX1 Pro198Leu, MnSOD Ala16Val, GSTM1, and GSTT1 gene polymorphisms are not associated with the risk of CML. This evidence concerns the gene SOD2 and chronic myelogenous leukemia, BCR-ABL1 positive.